Avenue Therapeutics, Inc. (ATXI) NASDAQ

0.71

-0.1399(-16.46%)

Updated at October 23 03:51PM

Currency In USD

Avenue Therapeutics, Inc.

Address

1140 Avenue of the America

New York City, NY 10036

United States of America

Phone

781 652 4500

Sector

Healthcare

Industry

Biotechnology

Employees

2

First IPO Date

June 27, 2017

Key Executives

NameTitlePayYear Born
Dr. Alexandra MacLean M.D.Chief Executive Officer & Director433,8001968
Dr. Scott A. Reines M.D., Ph.D.Interim Chief Medical Officer69,1201947
Dr. Lindsay Allan RosenwaldExecutive Director01955
Mr. David JinInterim Chief Financial Officer, Chief Operating Officer & Corporate Secretary01991

Description

Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was incorporated in 2015 and is based in New York, New York.